Segment Reporting - Summary of Disaggregated Amounts that Comprise Research and Development Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| External research and development expenses: | ||
| Clinical trials expenses | $ 755 | $ 528 |
| Consulting and outside services | 748 | 632 |
| Other external research and development | 2,442 | 3,960 |
| Total external research and development expenses | 3,945 | 5,120 |
| Internal research and development expenses: | ||
| Personnel related expenses | 2,798 | 2,570 |
| Total research and development expenses | $ 6,743 | $ 7,690 |
| X | ||||||||||
- Definition Clinical trials expenses. No definition available.
|
| X | ||||||||||
- Definition Consulting and outside services. No definition available.
|
| X | ||||||||||
- Definition External research and development expenses. No definition available.
|
| X | ||||||||||
- Definition External research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Internal research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Other external research and development. No definition available.
|
| X | ||||||||||
- Definition Personnel related expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|